| Serial Number | 90174058 |
| Word Mark | FIRJOIVA |
| Filing Date | Friday, September 11, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, September 19, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 22, 2021 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 20, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Monday, September 19, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, September 19, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, February 10, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 8, 2022 | SOU EXTENSION 1 GRANTED |
| Tuesday, February 8, 2022 | SOU EXTENSION 1 FILED |
| Tuesday, February 8, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, August 17, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 22, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 22, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 2, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 18, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, May 17, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, May 17, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 17, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, November 20, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, November 20, 2020 | NON-FINAL ACTION E-MAILED |
| Friday, November 20, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 18, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, October 20, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, September 15, 2020 | NEW APPLICATION ENTERED IN TRAM |